Unimed Announces 2025 Financial Results and Dividend Distribution
Unimed's board of directors, which met on May 14, 2026, approved the individual and consolidated financial statements for the 2025 fiscal year and decided to propose a dividend distribution of 0.625 dinars per share.
Key Financial Highlights
- The pharmaceutical laboratory has convened its Ordinary General Assembly for June 17, 2026.
- According to the published figures, the company's revenue reached 148.9 million dinars in 2025, compared to 147.7 million dinars in 2024, representing a slight increase of 1%.
- In contrast, the individual net income decreased by 9% to 16.8 million dinars, compared to 18.5 million dinars the previous year.
- On the consolidated side, the net income stood at 18.6 million dinars, down 4% from 2024, when it had reached 19.4 million dinars.
Analysis
These results reflect a globally stable activity in terms of revenue, despite a decline in profitability during the 2025 fiscal year. The proposed dividend distribution of 0.625 dinars per share demonstrates the company's commitment to rewarding its shareholders. The upcoming Ordinary General Assembly on June 17, 2026, will provide an opportunity for stakeholders to discuss the company's performance and future prospects.
